A peer reviewed article on Kadimastem’s AstroRx Cryopreserved off the Shelf Cell Product for the Treatment of ALS was Published in the Journal of Clinical Toxicology
–News Direct– Ness Ziona, Israel, January 25th 2024, Kadimastem (TASE: KDST), a well-known biotech company in the field of cellular therapy, which is in the clinical development stages of innovative…